Bionomics Total Assets 2022-2024 | NEUP
Bionomics total assets from 2022 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Bionomics Annual Total Assets
(Millions of US $) |
| 2024 |
$28 |
| 2023 |
$29 |
| 2022 |
$47 |
| 2021 |
$41 |
Bionomics Quarterly Total Assets
(Millions of US $) |
| 2024-09-30 |
$23 |
| 2024-06-30 |
$28 |
| 2023-09-30 |
$0 |
| 2023-06-30 |
$29 |
| 2022-12-31 |
$37 |
| 2022-06-30 |
$47 |
| 2021-06-30 |
$41 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
